Affiliated with a Castle Connolly Top Hospital
Who is Dr. Liedtke, Hematologist in Stanford, CA?
Dr. Michaela Liedtke, MD is a Hematologist, who primarily practices in Stanford, CA with 2 additional practice locations. She is board certified by the American Board of Internal Medicine. Dr. Liedtke graduated from Medizinische Hochschule Hannover and completed her residency at Albert Einstein College of Medicine. Dr. Liedtke is fluent in English and German, and is currently seeing new patients. Dr. Liedtke’s practice accepts Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Liedtke’s office at (650) 723-4000.
Where did Dr. Liedtke go to medical school and complete their residency?
Fellowship: Stanford University Medical Center CA | Memorial Sloan-Kettering Cancer Center NY | Stanford University Medical Center CA | Memorial Sloan-Kettering Cancer Center NY | Stanford University Medical Center, Stanford Ca - Bariatric Surgery
Residency: Albert Einstein College of Medicine | Albert Einstein College of Medicine Affiliated Hospitals
Medical School: Medizinische Hochschule Hannover | Hannover Medical School
Is Dr. Liedtke board certified in Hematologist?
Yes, Dr. Michaela Liedtke, MD is board certified by the American Board of Internal Medicine since 2006, American Board of Internal Medicine since 2005
What languages does Dr. Liedtke speak?
Dr. Liedtke and their clinical team can communicate with patients in the following languages:
English
German
What conditions does Dr. Liedtke treat?
As a Hematologist, Dr. Liedtke diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Liedtke. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Multiple Myeloma
- Multiple Myeloma in Remission
- Multiple Myeloma in Relapse
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ)
- Active multiple myeloma
- Untreated multiple myeloma
- Plasma cell myeloma
- Plasma Cell Myeloma in Remission', 'Kahler's Disease in Remission
- Myeloma in Remission
- Recurrent multiple myeloma
- Relapsed myeloma
- Myeloma recurrence
ICD-10 Codes:
- C9000: Multiple myeloma not having achieved remission
- C9001: Multiple myeloma in remission
- C9002: Multiple myeloma in relapse
Also known as:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia in Remission
- Acute Myeloid Leukemia
- Acute Leukemia
- Chronic Lymphocytic Leukemia
- Leukemia
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia Treatment (PDQ®)
- ALL
- Acute lymphocytic leukemia
- Lymphoblastic leukemia
- ALL Leukemia in Remission
- Acute Lymphoblastic Leukemia in Remission
- Childhood Leukemia in Remission
- AML Leukemia
- Acute Myeloblastic Leukemia
- Acute Myelogenous Leukemia
- Acute Blood Cancer
- Undifferentiated Acute Leukemia
- Fast-growing Blood Cancer
- CLL
- B-cell chronic lymphocytic leukemia
- Lymphocytic leukemia
- Blood Cancer
- Cancer of White Blood Cells
- Leukemia types
ICD-10 Codes:
- C9100: Acute lymphoblastic leukemia not having achieved remission
- C9101: Acute lymphoblastic leukemia, in remission
- C9200: Acute myeloblastic leukemia, not having achieved remission
- C9500: Acute leukemia of unspecified cell type not having achieved remission
- C9110: Chronic lymphocytic leukemia of B-cell type not having achieved remission
- C9590: Leukemia, unspecified not having achieved remission
Also known as:
- Light Chain Amyloidosis
- Amyloidosis
- Organ-Limited Amyloidosis
- Amyloidosis & Kidney Disease
- AL Amyloidosis
- Primary Amyloidosis
- Immunoglobulin Light Chain Amyloidosis
- Amyloid Disease
- Protein Deposit Disorder
- Localized Amyloidosis
- Amyloid Deposit in Organ
ICD-10 Codes:
- E8581: Light chain (AL) amyloidosis
- E859: Amyloidosis, unspecified
- E854: Organ-limited amyloidosis
Also known as:
- Monoclonal Gammopathy
- Blood Disorder
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ)
- MGUS
- Plasma Cell Disorder
- Gammopathy of Undetermined Significance
ICD-10 Codes:
- D472: Monoclonal gammopathy
Also known as:
- Waldenstrom Macroglobulinemia
- Lymphoma
- Waldenstrm macroglobulinemia
- Lymphoplasmacytic Lymphoma', 'WM Lymphoma', 'Waldenstrom's Disease
ICD-10 Codes:
- C880: Waldenstrom macroglobulinemia
Also known as:
- Cancer Chemotherapy
- Chemo treatment
- Oncology chemotherapy
- Cancer drug therapy
ICD-10 Codes:
- Z5111: Encounter for antineoplastic chemotherapy
Also known as:
- Chronic Diastolic Heart Failure
- Heart Failure
- Long-term Diastolic Heart Failure
- Chronic HFpEF
- Ongoing Filling Heart Failure
ICD-10 Codes:
- I5032: Chronic diastolic (congestive) heart failure
Also known as:
- Iron Deficiency Anemia
- Anemia
- Iron
- Anemia from Iron Lack
- Low Iron Anemia
- Sideropenic Anemia
ICD-10 Codes:
- D509: Iron deficiency anemia, unspecified
Also known as:
- Other Lymphoid Leukemia
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Unspecified lymphoid leukemia
- Atypical lymphoid leukemia
- Rare lymphoid leukemia
ICD-10 Codes:
- C91Z0: Other lymphoid leukemia not having achieved remission
Also known as:
- Bone Marrow Transplant
- Bone Marrow Transplantation
- Stem Cell Transplant
- Hematopoietic Stem Cell Transplant
- Marrow Transplant
ICD-10 Codes:
- Z9481: Bone marrow transplant status
Also known as:
- Other Abnormal Immune System Markers
- Unusual immune findings
- Abnormal immunology results
- Abnormal serum immunology
ICD-10 Codes:
- R768: Other specified abnormal immunological findings in serum
Which procedures does Dr. Liedtke perform as a Hematologist?
As a Hematologist, procedures performed by a Dr. Michaela Liedtke may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Liedtke's office.
Does Dr. Liedtke accept my insurance?
Dr. Liedtke accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Liedtke accept in Stanford, CA?
Dr. Liedtke in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Medicaid
Medicare
OptumRx
Santa Clara Family Health Plan
UnitedHealthcare
View All Insurances
Where is Dr. Liedtke's office located?
Recognitions
Awards
Doris Duke Foundation
Translational Research Award
ASCO
Young Investigator Award
Research grant, Hope Street Kids Foundation
Methods in Clinical Cancer Research Scholar, ASCO/AACR
Lymphoma Research Foundation
Fellowship Award
Stanford Department of Medicine
Translational Research Award
Publications
A single-center experience of the tionwide daunorubicin shortage
Leukemia & lymphoma, 2013
Lelidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain
Haematologica, 2013
AG10 inhibits amyloidogenesis
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2013
The prognostic value of diagnosing concurrent multiple myeloma
BRITISH JOURL OF HAEMATOLOGY, 2013
Sequential azacitidine plus lelidomide combition
Haematologica, 2013
Multiple Myeloma, Version 1.2013 Featured Updates to the NCCN Guidelines
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2013
Absolute lymphocyte count at day 28 independently predicts event-free
AMERICAN JOURL OF HEMATOLOGY, 2012
Safety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for
LEUKEMIA, 2012
Heart transplantation and cardiac amyloidosis: Approach to screening and novel magement strategies
JOURL OF HEART AND LUNG TRANSPLANTATION, 2012
Hemophagocytic lymphohistiocytosis in pregncy: A case report and review of treatment options.
Hematology (Amsterdam, Netherlands)
Phase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B
HAEMATOLOGICA-THE HEMATOLOGY JOURL, 2012
A Phase I Study of Sequential Azacitidine
Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., Go, 2010
Second-line mitoxantrone, etoposide
AMERICAN JOURL OF HEMATOLOGY, 2010
Plasma cell leukemia: concepts and magement.
Expert review of hematology, 2010
Surveillance imaging during remission identifies a group of patients with more favorable aggressive
ANLS OF ONCOLOGY, 2006
Regulation of Bcr-Abl-induced SAP kise activity
ONCOGENE, 1998
Effects of serum and plasma matrices on multiplex immunoassays.
Immunologic research, 2014
Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis
HEART RHYTHM, 2014
A single-center experience of the nationwide daunorubicin shortage
Leukemia & lymphoma, 2013
Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light
Haematologica, 2013
AG10 inhibits amyloidogenesis
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2013
The prognostic value of diagnosing concurrent multiple myeloma
BRITISH JOURNAL OF HAEMATOLOGY, 2013
Sequential azacitidine plus lenalidomide combination
Haematologica, 2013
Multiple Myeloma, Version 1.2013 Featured Updates to the NCCN Guidelines
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013
Amrubicin, a Novel Investigational Anthracycline
Dinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C.
A Phase I/II Study of Bortezomib
Dunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., Med
Absolute lymphocyte count at day 28 independently predicts event-free
AMERICAN JOURNAL OF HEMATOLOGY, 2012
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide
LEUKEMIA, 2012
More Than a Frog in the Throat A Case Series and Review of Localized Laryngeal Amyloidosis
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2012
Heart transplantation and cardiac amyloidosis
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012
Hemophagocytic lymphohistiocytosis in pregnancy: A case report and review of treatment options.
Hematology (Amsterdam, Netherlands)
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012
The Transcription Factor Encyclopedia
GENOME BIOLOGY, 2012
A Phase I Study of Sequential Azacitidine
Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., Go, 2010
Temozolomide In Acute Myeloid Leukemia
Medeiros, B. C., Kohrt, H. E., Rajwanshi, R., Gotlib, J., Coutre, S., , 2010
Second-line mitoxantrone, etoposide
AMERICAN JOURNAL OF HEMATOLOGY, 2010
Plasma cell leukemia: concepts and management.
Expert review of hematology, 2010
Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential
BLOOD, 2010
Therapeutic targeting of MLL
BLOOD, 2009
Reversible high-output cardiac failure, an unusual marker of disease status in multiple myeloma
LEUKEMIA & LYMPHOMA, 2008
Surveillance imaging during remission identifies a group of patients with more favorable aggressive
ANNALS OF ONCOLOGY, 2006
Regulation of Bcr-Abl-induced SAP kinase activity
ONCOGENE, 1998
A SITE-DIRECTED MUTAGENESIS STUDY TO IDENTIFY AMINO
BIOCHEMISTRY, 1992
What is Dr. Liedtke's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Liedtke's National Provider Identifier (NPI) number is 1609918556.
What common questions do patients ask about Dr. Liedtke?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Liedtke
What is Dr. Michaela Liedtke's specialty?
Dr. Liedtke is a Hematologist near Stanford, CA. An internist with advanced training specializing in disorders of the blood, spleen, and lymphatic system. This specialist manages conditions such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia, and lymphoma. Contact Dr. Liedtke to book an appointment today.
Is this Dr. Michaela Liedtke affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Liedtke is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Hematologist?
Explore Hematologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Michaela Liedtke accepting new patients in Stanford, CA?
Yes, Dr. Michaela Liedtke is accepting new patients at this time.
Does Dr. Michaela Liedtke offer online booking?
Please contact Dr. Liedtke's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Michaela Liedtke?
Please contact Dr. Liedtke's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Michaela Liedtke have?
Dr. Michaela Liedtke is certified by the American Board of Internal Medicine.
Other Hematologist Near Stanford, CA
Medical Oncologist
Accepting patientsMedical Oncologist
Accepting patientsHematologist
Accepting patients